https://de.marketscreener.com/kurs/aktie/SPERO-THERAPEUTICS-INC-38533873/news/Spero-Therapeutics-gibt-positive-Topline-Ergebnisse-der-klinischen-Phase-1-Studie-zur-bronchoalveol-39501936/?utm_source=telegram&utm_medium=social&utm_campaign=share